Detailed information for compound 1500315

Basic information

Technical information
  • TDR Targets ID: 1500315
  • Name: N-(4-acetamidophenyl)-4-(4-oxoquinazolin-3-yl )butanamide
  • MW: 364.398 | Formula: C20H20N4O3
  • H donors: 2 H acceptors: 3 LogP: 1.23 Rotable bonds: 8
    Rule of 5 violations (Lipinski): 1
  • SMILES: O=C(Nc1ccc(cc1)NC(=O)C)CCCn1cnc2c(c1=O)cccc2
  • InChi: 1S/C20H20N4O3/c1-14(25)22-15-8-10-16(11-9-15)23-19(26)7-4-12-24-13-21-18-6-3-2-5-17(18)20(24)27/h2-3,5-6,8-11,13H,4,7,12H2,1H3,(H,22,25)(H,23,26)
  • InChiKey: SCQRQYSFXJJKHB-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • N-(4-acetamidophenyl)-4-(4-oxo-3-quinazolinyl)butanamide
  • N-(4-acetamidophenyl)-4-(4-ketoquinazolin-3-yl)butyramide
  • ZINC05267108

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Echinococcus multilocularis 3 oxo 5 alpha steroid 4 dehydrogenase, C terminal 0.0051 1 1
Giardia lamblia Synaptic glycoprotein SC2 0.0051 1 0.5
Schistosoma mansoni synaptic glycoprotein sc2 related 0.0051 1 1
Entamoeba histolytica steroid 5-alpha reductase, putative 0.0051 1 0.5
Trypanosoma cruzi 3-oxo-5-alpha-steroid 4-dehydrogenase, putative 0.0051 1 0.5
Trichomonas vaginalis synaptic glycoprotein sc2, putative 0.0051 1 0.5
Loa Loa (eye worm) hypothetical protein 0.0051 1 1
Mycobacterium ulcerans hypothetical protein 0.0051 1 0.5
Onchocerca volvulus 0.0051 1 1
Trichomonas vaginalis synaptic glycoprotein sc2, putative 0.0051 1 0.5
Toxoplasma gondii 3-oxo-5-alpha-steroid 4-dehydrogenase 0.0051 1 0.5
Trichomonas vaginalis 3-oxo-5-alpha-steroid 4-dehydrogenase, putative 0.0051 1 0.5
Plasmodium vivax 3-oxo-5-alpha-steroid 4-dehydrogenase, putative 0.0051 1 0.5
Entamoeba histolytica trans-2,3-enoyl-CoA reductase, putative 0.0051 1 0.5
Plasmodium vivax polyprenol reductase, putative 0.0051 1 0.5
Trypanosoma cruzi 3-oxo-5-alpha-steroid 4-dehydrogenase, putative 0.0051 1 0.5
Plasmodium falciparum 3-oxo-5-alpha-steroid 4-dehydrogenase, putative 0.0051 1 0.5
Entamoeba histolytica 3-oxo-5-alpha-steroid 4-dehydrogenase domain-containing protein 0.0051 1 0.5
Echinococcus granulosus synaptic glycoprotein sc2 0.0051 1 1
Trypanosoma brucei 3-oxo-5-alpha-steroid 4-dehydrogenase-like, putative 0.0051 1 0.5
Leishmania major 3-oxo-5-alpha-steroid 4-dehydrogenase-like protein 0.0051 1 0.5
Trichomonas vaginalis conserved hypothetical protein 0.0051 1 0.5
Trichomonas vaginalis 3-oxo-5-alpha-steroid 4-dehydrogenase, putative 0.0051 1 0.5
Trichomonas vaginalis synaptic glycoprotein sc2, putative 0.0051 1 0.5
Brugia malayi 3-oxo-5-alpha-steroid 4-dehydrogenase 1 0.0051 1 1
Trichomonas vaginalis conserved hypothetical protein 0.0051 1 0.5
Trichomonas vaginalis 3-oxo-5-alpha-steroid 4-dehydrogenase, putative 0.0051 1 0.5
Plasmodium falciparum polyprenol reductase, putative 0.0051 1 0.5
Toxoplasma gondii 3-oxo-5-alpha-steroid 4-dehydrogenase 0.0051 1 0.5
Entamoeba histolytica hypothetical protein 0.0051 1 0.5
Trichomonas vaginalis 3-oxo-5-alpha-steroid 4-dehydrogenase, putative 0.0051 1 0.5
Trypanosoma cruzi 3-oxo-5-alpha-steroid 4-dehydrogenase, putative 0.0051 1 0.5
Echinococcus multilocularis synaptic glycoprotein sc2 0.0051 1 1
Toxoplasma gondii 3-oxo-5-alpha-steroid 4-dehydrogenase 0.0051 1 0.5
Loa Loa (eye worm) hypothetical protein 0.0051 1 1
Echinococcus granulosus 3 oxo 5 alpha steroid 4 dehydrogenase C terminal 0.0051 1 1
Schistosoma mansoni synaptic glycoprotein sc2 related 0.0051 1 1
Trypanosoma brucei 3-oxo-5-alpha-steroid 4-dehydrogenase, putative 0.0051 1 0.5
Loa Loa (eye worm) hypothetical protein 0.0051 1 1

Activities

Activity type Activity value Assay description Source Reference
Potency (functional) 50.1187 uM PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) 89.1251 uM PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] ChEMBL. No reference
Potency (functional) 89.1251 uM PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] ChEMBL. No reference

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.